flâneur

The Paths to Healthcare PLG (Part 1) - by Ben Lee

quiteafewclaims.substack.com · 2,195 words · saved by 1 readers

Special thanks to Brendan Keeler, Jay Rughani, Samir Unni, Matt Fisher, Aaron Maguregui, Alex Zhang, Dan Witte, Adam Steinle, Neha Katyal, Dave Bour, Paulius Mui, Blake Madden, Sage Khanuja for feedback, inspiration, legal review, or general perspectives that led to this post. This was a particularly challenging post to write due to the legal complexity, so really grateful for all the help. None of the below is endorsed by anyone listed; simply my thoughts. The promise of product-led distribution to end users in healthcare has been largely unfulfilled. This is primarily due to HIPAA’s restrictions around PHI exchange, driving Covered Entity organizations towards arduous review cycles. There are 5 currently established methods with which one could go direct-to-end-user. Product-Led Excitement; Non-PHI Workflows; Cash Pay Transactions; End User Represents Covered Entity; Patient Authorizations Pledge your support Over the past few years, with product-led-growth (PLG) proving its viabilit

The Paths to Healthcare PLG (Part 1) or How I Burned My Retinas Reading Up On HIPAA Ben Lee Jul 13, 2023 13 6 2 Share Special thanks to Brendan Keeler , Jay Rughani , Samir Unni , Matt Fisher , Aaron Maguregui , Alex Zhang , Dan Witte , Adam Steinle , Neha Katyal , Dave Bour , Paulius Mui , Blake Madden , Sage Khanuja for feedback, inspiration, legal review, or general perspectives that led to this post. This was a particularly challenging post to write due to the legal complexity, so really grateful for all the help. None of the below is endorsed by anyone listed; simply my thoughts. TL;DR: T

related reading